3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
12
Lymphoma
12
Leukemia
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Hodgkin Disease
7
Sarcoma
6
Neoplasms
6
Hematologic Neoplasms
6
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
5
Neuroblastoma
4
Multiple Myeloma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Myeloproliferative Disorders
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Breast Neoplasms
3
Vomiting
2
Testicular Neoplasms
2
Recurrence
2
Osteosarcoma
2
Neoplasm Metastasis
2
Nausea
2
Burkitt Lymphoma
2
Thalassemia
1
Teratoma
1
Seminoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
20
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
durvalumab
6
Ramucirumab
6
Radiofrequency Ablation
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
Mesna
×
Clear all
No trials found.